2 completed, 1 active not recruiting, 1 available, 1 enrolling by invitation. 4 Phase 1, 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 1, Withdrawn 1 |
| Phase 2 | 3 | Active not recruiting 1, Not yet recruiting 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow NuvOx LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic Glioblastoma (GBM) | Enrolling by invitation | NuvOx LLC | 40 | 2025-12-08 | 2026-02-18 | |
| NanO2 in Large VessEL Occlusion Stroke (NOVEL) NanO2TM, Sodium Chloride 0.9% Intravenous - Stroke Acute | Phase 2 | Not yet recruiting | NHS Greater Glasgow and Clyde | 172 | 2025-05-01 | 2025-04-04 |
| A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress dodecafluoropentane (0.025 mL/kg), dodecafluoropentane (0.032 mL/kg), dodecafluoropentane (0.050 mL/kg) - Mild Respiratory Distress | Phase 1 | Recruiting | NuvOx LLC | 18 | 2025-03-13 | 2026-01-28 |
| NanO2 for Large Vessel Occlusion Stroke Placebo, dodecafluoropentane emulsion (DDFPe) - Ischemic Stroke | Phase 2 / Phase 3 | Unknown | NuvOx LLC | 300 | 2023-04-01 | 2022-05-25 |
| A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM NanO2TM, Placebo Saline Infusion - Glioblastoma Multiforme | Phase 2 | Active not recruiting | NuvOx LLC | 87 | 2023-03-31 | 2026-08-06 |
| A Phase Ib Study of NVX-508 in Sickle Cell Disease NVX-508 - Sickle Cell Disease | Phase 1 | Withdrawn | Amma Owusu-Ansah, MD | 2018-07-01 | 2018-07-16 | |
| A Phase Ib/II in Patients With Acute Ischemic Stroke 0.05 mL/kg DDFPe, 0.05 mL/kg Placebo, 0.10 mL/kg DDFPe - Ischemic Stroke | Phase 1 | Completed | NuvOx LLC | 24 | 2017-02-01 | 2021-09-24 |
| The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma NVX-108 - Glioblastoma Multiforme | Phase 1 | Completed | NuvOx LLC | 11 | 2014-05-01 | 2019-02-28 |
| NuvOx Expanded Access NanO₂ - Glioblastoma, Respiratory Distress Syndrom | Available | NuvOx LLC | 2026-08-05 |
Glioblastoma (4) · Ischemic Stroke (3) · Anemia, Sickle Cell (1) · Dyspnea (1) · Stroke (1)
perfluoropentane (3) · Sodium Chloride (1)
United States (3) · Australia (1) · Canada (1) · United Kingdom (1)
Amma T Owusu-Ansah, MD (1) · Jason Lickliter, MBBSPhDFRACP (1) · Sanjeeva Onteddu, MD (1) · William Culp, MD (1)
R44CA298498 (1)